News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Merck & Co., Inc. Sues Teva Pharmaceutical Industries Limited to Block Generic Vytorin
March 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg News -- Merck & Co. and its Schering unit is suing Teva Pharmaceutical Industries Ltd. to prevent it from selling a generic version of the cholesterol drug Vytorin in the United States until 2017.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Merck & Co.
MORE ON THIS TOPIC
Government
RFK Jr. Firm on HHS Cuts, Wobbles on Measles Vaccine
May 15, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
CMS Prepares for Third Cycle of Drug Negotiations as Trump Intensifies Push To Lower Prices
May 13, 2025
·
3 min read
·
Tristan Manalac
Pharmacy benefit managers
Trump’s Most Favored Nation Policy Sparks PBM Selloff
May 13, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
Trump’s Drug Pricing Order ‘More Bark Than Bite’
May 12, 2025
·
5 min read
·
Annalee Armstrong
